Board Description
Tarsa Therapeutics is developing OSTORA, an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Board Type
Tarsa Therapeutics is developing OSTORA, an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.